Ando M
First Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan.
Nihon Shokakibyo Gakkai Zasshi. 1992 Oct;89(10):2586-93.
Using the ANIT induced model of cholestasis in rats, the therapeutic effects of UDCA to the intrahepatic cholestasis were evaluated by changes of serum chemistry and liver histology. ANIT was administered once at a dosage of 40 mg/kg b.w. per os and UDCA was given ad libitum for 7 days by a drinking water containing UDCA at 0.5 and 5.0% solution. In the period of bile duct epithelial degeneration and necrosis, effects of UDCA for jaundice was not detected, but hepato-cellular disturbances were appeared histologically. Moreover, the elevation of serum levels of chenodeoxy-cholic acid, deoxycholic acid and lithocholic acid was accompanied. On the other hand, in the recovery stage of the bile duct epithelium, serum bilirubin was decreased significantly in the UDCA group which seemed to be related with the potent choleretic effect of UDCA. These results may indicate that UDCA is effective for the intrahepatic cholestasis in the case with no bile duct epithelial damage but in the presence of it hepato-cellular injury is introduced by the accumulated toxic bile acids in the blood.
采用ANIT诱导的大鼠胆汁淤积模型,通过血清生化指标变化和肝脏组织学改变评估熊去氧胆酸(UDCA)对肝内胆汁淤积的治疗效果。ANIT以40mg/kg体重的剂量经口一次性给药,UDCA通过含0.5%和5.0%溶液的饮用水自由饮用7天。在胆管上皮细胞变性坏死期,未检测到UDCA对黄疸的影响,但组织学上出现肝细胞紊乱。此外,血清鹅去氧胆酸、脱氧胆酸和石胆酸水平升高。另一方面,在胆管上皮细胞恢复期,UDCA组血清胆红素显著降低,这似乎与UDCA强大的利胆作用有关。这些结果可能表明,UDCA对无胆管上皮损伤的肝内胆汁淤积有效,但在存在胆管上皮损伤的情况下,血液中蓄积的毒性胆汁酸会导致肝细胞损伤。